CAMACHO MOLL, MARIA ELENA
CIENCIAS DE LA VIDA · Nivel 1
Desde 2018 es Investigador Asociado en Instituto Mexicano del Seguro Social
Información*
| Nombre | MARIA ELENA CAMACHO MOLL |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | BIOQUÍMICA |
| Especialidad | BIOLOGIA MOLECULAR |
| CVU | 363743 |
| Institución | |
|---|---|
| Dependencia | OOAD NUEVO LEON |
| Entidad | NUEVO LEON |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2025 |
| Fin: 31/12/2029 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2025
- Factors associated with infection and hospitalization of Zika cases during the 2016–2018 outbreak in Mexico Scientific Reports
- Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study Vaccines
- 2024
- Cardiovascular Risk Factors as Predictors of Nutritional Status in Older Mexican Adults Nutrients
- The impact of comorbidity status in COVID-19 vaccines effectiveness before and after SARS-CoV-2 omicron variant in northeastern Mexico: a retrospective multi-hospital study Frontiers in Public Health
- Paxlovid TM reduces the incidence of pneumonia, hospitalization, and death in a cohort of COVID-19 patients from northeast Mexico Journal of Infection and Public Health
- Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma International Journal of Molecular Sciences
- 2023
- ESX-3 secretion system in Mycobacterium: An overview Biochimie
- Side Effects of COVID-19 Vaccines in Pregnant and Lactating Mexican Women and Breastfed Infants: A Survey-Based Study Vaccines
- Sex, Age, and Comorbidities Are Associated with SARS-CoV-2 Infection, COVID-19 Severity, and Fatal Outcome in a Mexican Population: A Retrospective Multi-Hospital Study. Journal of clinical medicine
- ABC-GOALScl score predicts admission to the intensive care unit and mortality of COVID-19 patients over 60 years of age. BMC geriatrics
